C. Alm

发表

Global Analysis of mRNA Localization Reveals a Prominent Role in Organizing Cellular Architecture and Function

P. Tomançak, T. Hughes, T. Babak, 2007, Cell.

Global analysis of mRNA localization reveals a prominent role in the organization of cellular architecture and function

P. Tomançak, T. Babak, E. Lécuyer, 2008 .

DEBRISOQUINE HYDROXYLATION POLYMORPHISM AND PERSONALITY

C. Alm, L. Bertilsson, D. Schalling, 1989, The Lancet.

Quantification of the O- and N-demethylated and the glucuronidated metabolites of codeine relative to the debrisoquine metabolic ratio in urine in ultrarapid, rapid, and poor debrisoquine hydroxylators.

C. Alm, J. Svensson, Q. Yue, 1997, Therapeutic drug monitoring.

Parental Diabetes: The Akita Mouse as a Model of the Effects of Maternal and Paternal Hyperglycemia in Wildtype Offspring

C. Alm, M. Bouxsein, M. Grynpas, 2012, PloS one.

Maternal perinatal diet induces developmental programming of bone architecture.

C. Alm, M. Bouxsein, M. Palmert, 2013, The Journal of endocrinology.

In Vitro and In Vivo Studies on the Disposition of Mirtazapine in Humans

C. Alm, L. Bertilsson, C. Elwin, 1997 .

Lack of relationship between glibenclamide metabolism and debrisoquine or mephenytoin hydroxylation phenotypes.

C. Alm, L. Bertilsson, I. Christenson, 1990, British journal of clinical pharmacology.

Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test.

C. Alm, L. Bertilsson, A. Llerena, 1994, British journal of clinical pharmacology.

Interindividual and interethnic differences in the demethylation and glucuronidation of codeine.

C. Alm, F. Sjöqvist, J. Svensson, 1989, British journal of clinical pharmacology.

Stereoselective disposition of mianserin is related to debrisoquin hydroxylation polymorphism

C. Alm, L. Bertilsson, C. Elwin, 1994, Clinical pharmacology and therapeutics.

Quality of chloroquine preparations marketed in Dar es Salaam, Tanzania

C. Alm, A. Massele, Ö. Ericsson, 1995, The Lancet.

S‐mephenytoin hydroxylation phenotypes in a Swedish population determined after coadministration with debrisoquin

C. Alm, L. Bertilsson, T. Villén, 1989, Clinical pharmacology and therapeutics.

Intraindividual and interindividual variability in the disposition of the local anesthetic ropivacaine in healthy subjects.

C. Alm, L. Gustafsson, S. Sandin, 1997, Therapeutic drug monitoring.

Investigation of peripubertal expression of Lin28a and Lin28b in C57BL/6 female mice

C. Alm, M. Palmert, A. Grieco, 2013, Molecular and Cellular Endocrinology.

Slow chloroguanide metabolism in Tanzanians compared with white subjects and Asian subjects confirms a decreased CYP2C19 activity in relation to genotype

C. Alm, L. Bertilsson, A. Massele, 2000, Clinical pharmacology and therapeutics.

Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotype.

C. Alm, M. Ingelman-Sundberg, L. Bertilsson, 1999, Pharmacogenetics.

Involvement of CYP2D6 but not CYP2C19 in nicergoline metabolism in humans.

C. Alm, L. Bertilsson, P. Dostert, 2003, British journal of clinical pharmacology.

Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: An interaction study with fluvoxamine and ketoconazole as in vivo inhibitors

C. Alm, L. Bertilsson, L. Gustafsson, 1998, Clinical pharmacology and therapeutics.

Systemic Absorption and Block after Epidural Injection of Ropivacaine in Healthy Volunteers

C. Alm, L. Gustafsson, J. Persson, 1997, Anesthesiology.

Identification of a glycosphingolipid transfer protein GLTP1 in Arabidopsis thaliana

C. Alm, T. Salminen, J. Edqvist, 2008, The FEBS journal.

Haloperidol disposition is dependent on debrisoquine hydroxylation phenotype.

C. Alm, L. Bertilsson, A. Llerena, 1992, Therapeutic drug monitoring.

Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation.

C. Alm, F. Sjöqvist, J. Svensson, 1989, British journal of clinical pharmacology.

Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine.

C. Alm, L. Bertilsson, M. Dahl, 2000, Therapeutic drug monitoring.

Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast‐dissolving tablets to fasting healthy volunteers

C. Alm, H. Hedenström, A. Grahnén, 1997, Alimentary pharmacology & therapeutics.

Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity

C. Alm, L. Bertilsson, M. Dahl, 1996, Clinical pharmacology and therapeutics.

Hippocampal volumes differ across the mouse estrous cycle, can change within 24hours, and associate with cognitive strategies

Jason P. Lerch, Mark R. Palmert, Shoshana Spring, 2013, NeuroImage.

Comparative in vitro and in vivo study of a sugar-coated chloroquine preparation marketed in Tanzania versus an ordinary brand

C. Alm, A. Massele, Ö. Ericsson, 1945 .

Essential Loci in Centromeric Heterochromatin of Drosophila melanogaster. I: The Right Arm of Chromosome 2

C. Alm, A. Hilliker, P. Dimitri, 2010, Genetics.

Characterization of SCP‐2 from Euphorbia lagascae reveals that a single Leu/Met exchange enhances sterol transfer activity

C. Alm, T. Salminen, J. Edqvist, 2006, The FEBS journal.

Disposition of perphenazine is related to polymorphic debrisoquin hydroxylation in luman beings

C. Alm, L. Bertilsson, C. Nordin, 1989, Clinical pharmacology and therapeutics.

Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotype

C. Alm, L. Bertilsson, A. Massele, 1998, Clinical pharmacology and therapeutics.

Polymorphic 2-hydroxylation of desipramine

C. Alm, M. Ingelman-Sundberg, L. Iselius, 1993, European Journal of Clinical Pharmacology.

Comparative in vitro and in vivo study of a sugar‐coated chloroquine preparation marketed in Tanzania versus an ordinary brand

C. Alm, A. Massele, L. Gustafsson, 2001, Journal of clinical pharmacy and therapeutics.